GSE253554 CHRDL2 overexpression Caco-2 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE253554_CHRDL2 overexpression_Caco-2_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE253554_CHRDL2 overexpression_Caco-2_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE253554_CHRDL2 overexpression_Caco-2_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE253554_CHRDL2 overexpression_Caco-2_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

SNX10 antisense RNA 1

Gene

RNA, 7SL, cytoplasmic 4, pseudogene

Gene

UMODL1 antisense RNA 1

Gene

uncharacterized LOC124909451

Gene

uncharacterized LOC105370061

Gene

RNA, 7SL, cytoplasmic 364, pseudogene

Gene

microRNA 3181

Gene

RNA, U6 small nuclear 1280, pseudogene

Gene

uncharacterized LOC124904643

Gene

ribosomal protein L34 pseudogene 32

  • Gene

    SNX10 antisense RNA 1


  • Gene

    RNA, 7SL, cytoplasmic 4, pseudogene


  • Gene

    UMODL1 antisense RNA 1


  • Gene

    uncharacterized LOC124909451


  • Gene

    uncharacterized LOC105370061


  • Gene

    RNA, 7SL, cytoplasmic 364, pseudogene



  • Gene

    RNA, U6 small nuclear 1280, pseudogene


  • Gene

    uncharacterized LOC124904643


  • Gene

    ribosomal protein L34 pseudogene 32

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.